Published June 20, 2022
| Version 1.0.0
Dataset
Open
Virtual screening on Nsp16: screening of 1084 compounds in VeroE6-eGFP cells
Description
This report describes the most relevant results of virtually screening the Janssen Pharmaceutica compound collection for potential activity against SARS-CoV-2 Nsp16 and confirmation of potential hits in a VeroE6 cell-based anti-SARS-CoV-2 assay.
Files
Files
(195.7 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:4b7220a845fc352f48afdabc2e3a24f9
|
195.7 kB | Download |